Literature DB >> 25413312

Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR).

Rebecca Marcantuono1, Jacob Gutsche, Maureen Burke-Julien, Saif Anwaruddin, John G Augoustides, David Jones, Lisa Mangino-Blanchard, Nicole Hoke, Stephanie Houseman, Robert Li, Prakash Patel, Robert Stetson, Elizabeth Walsh, Wilson Y Szeto, Howard C Herrmann.   

Abstract

BACKGROUND: The care pathway for patients undergoing transcatheter aortic valve replacement (TAVR), particularly in the US, was initially based on open surgical techniques and often includes general anesthesia, transesophageal echocardiographic monitoring, and cardiothoracic intensive care unit (ICU) stays. Whether a subgroup of patients could benefit from early extubation, fewer days in the ICU, and early ambulation in terms of both cost and effectiveness is unknown. METHODS AND
RESULTS: A fast track (FT) protocol was initiated at two institutions in our health system with specific inclusion criteria. Patients with complications or morbidity post procedure deemed ineligible to continue on the FT pathway were designated as deviations. Baseline characteristics, success and deviations, subsequent course, and direct costs were compared for FT eligible and ineligible patients over a 6-month study period. Among 99 patients undergoing Transfemoral TAVR, 39 (39%) met FT inclusion criteria. The mean age of eligible and ineligible patients was similar at 85 years, but by design, eligible patients had fewer co-morbid conditions. Successful completion of the FT protocol was achieved in 28 patients (72%). Patients on the FT had shorter ICU stays (28 ± 103 vs 45 ± 46 hours, P < 0.0001) and post-operative length of stay (4.3 ± 4.4 vs 7.2 ± 5.3 days, P < 0.0001), and incurred lower direct costs ($44,923 ± $14,187 vs $56, 339 ± 17,808, P < 0.0001).
CONCLUSIONS: It is feasible to identify a large percentage of suitable patients preprocedure who are eligible for a FT postprocedure care pathway. There was no evidence for compromise of care and successful completion of the pathway was associated with shorter length of stay and fewer direct costs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  aortic stenosis; transcatheter aortic valve replacement

Mesh:

Year:  2014        PMID: 25413312     DOI: 10.1002/ccd.25749

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  7 in total

1.  Safe implementation of enhanced recovery after surgery protocol in transfemoral transcatheter aortic valve replacement.

Authors:  Molly Szerlip; Deborah Tabachnick; Mohanad Hamandi; LuAnn Caras; Allison T Lanfear; John J Squiers; Katherine Harrington; Srinivasa P Potluri; J Michael DiMaio; Jordan Wooley; Benjamin Pollock; Justin M Schaffer; William T Brinkman; David L Brown; Michael J Mack
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-23

2.  Reducing Hospital Admissions for Paracentesis: A Quality Improvement Intervention.

Authors:  Shazia Mehmood Siddique; Stefanie Porges; Meghan Lane-Fall; Shivan J Mehta; William Schweickert; Joan Kinniry; April Taylor; James D Lewis; Shaz Iqbal; David Goldberg; Judy A Shea; Robert Stetson; Mary Coniglio; Maarouf Hoteit; Neil Fishman; Vandana Khungar
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-10       Impact factor: 11.382

3.  Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

Authors:  Matthew R Reynolds; Yang Lei; Kaijun Wang; Khaja Chinnakondepalli; Katherine A Vilain; Elizabeth A Magnuson; Benjamin Z Galper; Christopher U Meduri; Suzanne V Arnold; Suzanne J Baron; Michael J Reardon; David H Adams; Jeffrey J Popma; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2016-01-05       Impact factor: 24.094

4.  Two-year post-discharge costs of care among patients treated with transcatheter or surgical aortic valve replacement in Germany.

Authors:  Klaus Kaier; Frederike von Kampen; Hardy Baumbach; Constantin von Zur Mühlen; Philip Hehn; Werner Vach; Manfred Zehender; Christoph Bode; Jochen Reinöhl
Journal:  BMC Health Serv Res       Date:  2017-07-11       Impact factor: 2.655

Review 5.  Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease.

Authors:  Tasalak Thonghong; Ole De Backer; Lars Søndergaard
Journal:  Open Heart       Date:  2018-02-23

6.  Simplification and optimization of transcatheter aortic valve implantation - fast-track course without compromising safety and efficacy.

Authors:  Manik Chopra; Ngai H V Luk; Ole De Backer; Lars Søndergaard
Journal:  BMC Cardiovasc Disord       Date:  2018-12-10       Impact factor: 2.298

7.  Remote Monitoring of Patients Undergoing Transcatheter Aortic Valve Replacement: A Framework for Postprocedural Telemonitoring.

Authors:  Mathilde C Hermans; Martijn S Van Mourik; Hermie J Hermens; Jan Baan; Marije M Vis
Journal:  JMIR Cardio       Date:  2018-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.